newsfilter
← Latest News
GlobeNewswire·

Oyster Point Pharma Announces Retirement of William J. Link From Board of Directors

PRINCETON, N.J., March 17, 2022 (GLOBE NEWSWIRE) -- Oyster Point Pharma, Inc. (NASDAQ:OYST), a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class pharmaceutical therapies to treat op